HMGB1-mediated apoptosis and autophagy in ischemic heart diseases

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Cellular Stress Responses

Background:

• Acute myocardial infarction (MI) is a leading cause of death globally, with cardiomyocyte death and cardiac remodeling being major consequences.
• Apoptosis was considered the primary cell death pathway post-MI, but recent findings highlight autophagy's protective role against ischemic stress.
• The interplay between apoptosis and autophagy following MI is complex and actively researched.

Purpose of the Study:

• To review the regulatory role of high-mobility group box 1 (HMGB1) in apoptosis and autophagy following myocardial infarction.
• To elucidate the molecular mechanisms and crosstalk between these two cellular processes in ischemic heart disease.
• To identify HMGB1 as a key regulator in the context of cardiomyocyte survival and myocardial remodeling.

Main Methods:

• Literature review focusing on molecular mechanisms and cellular responses in ischemic heart disease.
• Analysis of recent research on the role of HMGB1 in regulating apoptosis and autophagy.
• Synthesis of findings regarding the crosstalk between cell death pathways.

Main Results:

• HMGB1, a nuclear protein, plays a significant role in regulating both apoptosis and autophagy in cardiomyocytes.
• The interaction between apoptosis and autophagy is intertwined, with HMGB1 acting as a central modulator.
• HMGB1 influences cardiomyocyte fate and myocardial remodeling post-MI through its effects on these pathways.

Conclusions:

• HMGB1 is a critical regulator of the balance between apoptosis and autophagy in the context of myocardial infarction.
• A deeper understanding of HMGB1's function in ischemic heart disease can guide the development of novel therapeutic strategies.
• Targeting HMGB1 may offer a promising approach to promote cardiomyocyte survival and reduce tissue damage after MI.